Alan Rigby

Dr. Alan Rigby is a passionate and innovative oncology leader with over 20 years of academic and industry experience in the area of data driven oncology drug discovery from concept to clinical candidate to genetically enabled first-in-man studies.

Alan is a Founder of HiberCell where he is currently a Senior Board Advisor to the company. Previously, Alan held the role of chief scientific officer of Warp Drive Bio., a Cambridge based biotechnology company. Alan joined Warp Drive Bio following a tenure as senior vice president and chief scientific officer at Synta Pharmaceuticals. While at Synta Alan led research and development efforts for Synta’s HSP90 clinical candidate, Ganetespib, as well as restructuring the preclinical small molecule drug conjugate platform.